Abbott Toxicology

What Abbott Toxicology does

Abbott Toxicology is a division of Abbott Laboratories (NYSE: ABT) that provides drug and alcohol testing devices, immunoassay reagents, and laboratory confirmation services for workplace, government, clinical, and physician office customers globally. Its core technology is rooted in immunoassay chemistry, including proprietary SEFRIA (β-galactosidase-based) and HEIA homogeneous enzyme immunoassays, ELISA reagents for forensic specimens, and lateral flow point-of-care devices for urine, oral fluid, blood, and surface testing. Key product brands include iCup and iScreen urine cups, SoToxa oral fluid mobile test system, Quantisal oral fluid collection devices, SureStep international screening line, AlcoMate and Alco-Sensor FST breath alcohol testers, and the Signify ER kit for Japan. The division operates five world-class laboratories in the US and UK for GC-MS and LC-MS/MS confirmation testing and result reporting via the DATALINK platform, and has expanded its panel coverage to include fentanyl, novel psychoactive substances, and other emerging drugs.

Abbott Toxicology makes money through three primary streams: sale of rapid point-of-care screening hardware (cups, dip cards, cassettes, oral fluid devices, breath testers), recurring reagent and consumable revenue (SEFRIA, HEIA, ELISA) tied to installed chemistry analyzers, and centralized laboratory testing services. Pricing is quote-based via direct enterprise sales, with multi-year contracts and distributor partnerships in regional markets. The go-to-market motion is sales-led through regional sales offices in North America, Europe, Asia Pacific, Latin America, and the Middle East, supported by digital content marketing, webinars, customer training (Learning Xchange), and dedicated government services and workplace solutions divisions. The customer base spans four vertical-aligned use cases — workplace screening, government (law enforcement, criminal justice), clinical toxicology, and physician office labs — with named customers in transportation (SJ Sweden, Transafe), law enforcement (Guardia Civil Spain), and construction (Ainscough Crane Hire).

The division has grown historically through acquisitions including Immunalysis (forensic toxicology reagents, Pomona CA) and eScreen (workplace testing lab and technology services), and has expanded its product portfolio to address emerging drug trends and regulatory frameworks across DOT, FDA 510(k), EWDTS, EU MDR (CE), and Japan PMDA approvals. Within Abbott's diversified diagnostics franchise, the toxicology unit functions as a global, regulation-led business with an integrated hardware-reagents-services model and a footprint across 25+ countries.

Name

Abbott Toxicology

Legal name

Abbott Laboratories (parent company); Abbott Rapid Diagnostics (division brands)

Website

https://toxicology.abbott

Company type

Public

Founded year

1888

Operating status

Operating

Headcount range

101–250 employees

Short description

Abbott Toxicology is the drug and alcohol testing division of Abbott Laboratories, providing rapid point-of-care screening devices, immunoassay reagents, and centralized laboratory confirmation services to workplace, government, clinical, and physician office customers across 25+ countries.

Ownership category

akta.pro rank

Product category

Drug & Alcohol Testing Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

Keywords

• Drug screening devices
• Toxicology laboratory services
• Immunoassay reagents
• Breath alcohol testing
• Workplace drug testing

Headquarters

HQ city

North Kansas City

HQ country

United States

HQ region

North America

Offices27 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Rapid Screening Devices: Sale of point-of-care drug and alcohol testing devices including urine cups, dip cards, cassettes, strips, oral fluid tests, and breath alcohol testers. Products sold directly to workplaces, government agencies, and healthcare providers.
2. Reagents and Consumables: Sale of immunoassay reagents (SEFRIA, HEIA, ELISA) for drug screening. Includes assays, calibrators, and controls for use on chemistry analyzers in laboratory settings.
3. Laboratory Testing Services: Centralized laboratory drug testing services including urine, oral fluid, and hair testing. Services include confirmation testing using GC-MS and LC-MS/MS methods, with online result reporting systems.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Abbott Toxicology manufactures and sells rapid point-of-care drug and alcohol screening devices (urine cups, oral fluid testers, breath alcohol analyzers), immunoassay reagents (SEFRIA, HEIA, ELISA) for laboratory use, and operates centralized laboratory drug testing services using GC-MS and LC-MS/MS confirmation methods. The company serves workplace, government, clinical, and physician office laboratory segments globally with five world-class laboratories in the US and UK.

Product overview

Abbott Toxicology provides a comprehensive portfolio of drug and alcohol testing products and laboratory services organized into three core pillars: rapid point-of-care screening devices, laboratory reagents, and laboratory testing services. The rapid screening device portfolio includes the iCup™ and iScreen™ branded urine test cups (including FUO, DX, Click Cup, Round Cup, Square Cup, Slim Cup formats), E-Z Split Key™ cups, dip cards, cassettes, strips, and adulteration test strips; the SoToxa™ handheld oral fluid mobile test system; iScreen™ and OrALert™ oral fluid screening devices; and the AlcoMate® and Alco-Sensor FST® breath alcohol testers. The SureStep™ product line (cups, dip cards, cassettes, strips, adulteration strips, powder test panels, blood test cassettes, and twist screen devices) serves as a parallel international brand. Abbott also offers oral fluid collection devices (Quantisal™ and Quantisal™ II), and the Signify ER device (Japan market). The reagents portfolio spans SEFRIA™ and HEIA™ immunoassay reagents for urine and oral fluid matrices, plus ELISA reagents for forensic toxicology screening. Laboratory services include urine, oral fluid, and hair drug testing, supported by online result reporting systems. The company operates five world-class laboratories in the US and UK and serves customers across workplace, government, clinical, and physician office laboratory segments.

Differentiator

Problem solved

Functional benefit

Brands

• iCup: iCup Urine Test Drug Screen Cup - self-contained onsite urine drug screening device, company's most widely used rapid drug test cup
• iScreen
• SureStep
• SEFRIA
• HEIA
• ELISA
• SoToxa
• ABON
• AlcoMate
• OrALert
• Quantisal
• Verum Drug Panel
• Signify ER

Products and services

• iCup™ Urine Test Drug Screen Cup

Quantifiable outcome

• iCup provides results in 5 minutes with self-contained collection minimizing collector exposure to urine
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Roche Diagnostics: Major diagnostics company whose clinical chemistry/immunoassay platforms and laboratory services overlap with Abbott Toxicology's reagent and laboratory offerings in clinical settings.
• Thermo Fisher Scientific: Large life sciences tools company offering immunoassay reagents, mass spectrometry instruments, and laboratory services that overlap with Abbott's reagent and confirmation testing business.
• Siemens Healthineers: Diversified diagnostics vendor operating clinical chemistry/immunoassay analyzers that compete with Abbott's SEFRIA/HEIA reagent chemistries in hospital and reference labs.

Emerging players

• OraSure Technologies: Specialist in oral fluid collection devices (Intercept) used for drug testing. Competes with Abbott's Quantisal/Quantisal II and SoToxa oral fluid drug testing products.
• Bio-Rad Laboratories: Life science tools manufacturer with clinical diagnostics and immunoassay reagents that overlap with Abbott Toxicology's reagent product portfolio for toxicology labs.

Direct peers

• Clinical Reference Laboratory: Specialized toxicology and clinical reference lab providing urine and oral fluid drug testing for employers, government, and clinical clients. Comparable lab services portfolio.
• Quest Diagnostics: Largest US independent medical laboratory providing urine, oral fluid, and hair drug testing services to employers and government. Directly comparable to Abbott Toxicology's central lab drug testing and employer services.
• Psychemedics Corporation: Specialist in hair-based drug testing for workplace and legal markets. Directly comparable to Abbott Toxicology's hair testing laboratory services and employer customer base.
• Omega Laboratories: Toxicology testing laboratory focused on hair, urine, and oral fluid drug screening for workplace and legal markets. Direct competitor to Abbott's central lab toxicology services.
• Laboratory Corporation of America (Labcorp): Major clinical and toxicology laboratory offering workplace drug testing, forensic toxicology, and confirmation services. Competes head-to-head with Abbott Toxicology in lab-based drug screening.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/78895

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbott Toxicology